Press Releases & Awards

MicroGen Diagnostics, the industry leader in providing next-generation DNA sequencing (NGS) for clinical diagnostics, announces its entry into oral microbial diagnostics with the PerioDX test. PerioDX is the first commercially available saliva-based periodontal test to combine quantitative polymerase chain reaction (qPCR) and NGS technology for comprehensive DNA diagnostic results. PerioDX identifies 17 antibiotic resistance genes and all clinically relevant microbes in a sample,1 thereby assisting clinicians both with treatment choices and promoting antimicrobial stewardship. Click Here to Read Full Article…

ORLANDO, Fla., May 24, 2021 /PRNewswire/ — MicroGen Diagnostics, the industry leader in providing next-generation DNA sequencing (NGS) for clinical diagnostics, has introduced OrthoKEY, an innovative approach to address current clinical shortcomings in the diagnosis of orthopedic infections. OrthoKEY brings accuracy, sensitivity, timeliness, and affordability to PJI diagnostics and management for the clinic and operating room.…

ORLANDO, Fla., Sep 1, 2021 /PRNewswire/ — MicroGen Diagnostics, the industry leader in providing Next-Generation DNA Sequencing (NGS) for clinical diagnostics, has acquired its RTL Genomics partner lab to expand expertise and capacity in non-clinical primary research. …

ORLANDO, Fla., May 24, 2021 /PRNewswire/ — MicroGen Diagnostics (MicroGenDX) is pleased to announce that it has resolved a dispute with AdventHealth concerning Covid-19 testing services that were provided to AdventHealth during the height of the global pandemic in May of 2020.…